ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 017,94
0,76%
Dow Jones
38 675,68
1,18%
DAX
18 158,68
0,92%
Brent Oil
83,585
0,55%
Bitcoin
64 018,83
0,03%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Virios Therapeutics Inc (VIRI)

  7. Virios Therapeutics Inc (VIRI) Actualités

VIRI Virios Therapeutics Inc

0,4115
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:16:43
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Virios Therapeutics Inc VIRI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,4115 10:16:43
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,4115
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202415:15GLOBEVirios Therapeutics to Report First Quarter 2024 Financial..
26/3/202414:15GLOBEVirios Therapeutics Announces Publication of International..
08/3/202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/3/202422:30EDGAR2Form 8-K - Current report
01/3/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:25EDGAR2Form 8-K - Current report
29/2/202415:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
28/2/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:15GLOBEVirios Therapeutics Issues Shareholder Letter..
27/2/202422:15EDGAR2Form 8-K - Current report
02/2/202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
22/1/202415:33EDGAR2Form PRE 14A - Other preliminary proxy statements
22/1/202415:00GLOBEVirios Therapeutics Announces Plans to Advance..
03/1/202413:05EDGAR2Form 8-K - Current report
02/1/202413:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
13/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:20EDGAR2Form 8-K - Current report
13/11/202313:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
07/11/202313:29EDGAR2Form 8-K - Current report
06/11/202313:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
02/11/202312:05EDGAR2Form 8-K - Current report
12/10/202313:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
18/9/202313:16EDGAR2Form 8-K - Current report
18/9/202313:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
12/9/202313:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
22/8/202321:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202313:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
11/8/202314:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:15EDGAR2Form 8-K - Current report
10/8/202313:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
09/8/202313:15EDGAR2Form 8-K - Current report
09/8/202313:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
03/8/202322:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
17/7/202313:15EDGAR2Form 8-K - Current report
17/7/202313:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
14/7/202322:25EDGAR2Form 8-K - Current report
14/7/202322:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/5/202322:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
15/5/202313:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
11/5/202313:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
VIRI
Virios Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés